Brian Evanko Sells 5,368 Shares of Cigna Group (NYSE:CI) Stock

Cigna Group (NYSE:CI) insider Brian Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Cigna Group Stock Down 0.2%

Shares of Cigna Group stock opened at $306.57 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The stock has a market capitalization of $81.83 billion, a PE ratio of 16.73, a price-to-earnings-growth ratio of 0.90 and a beta of 0.45. Cigna Group has a 52-week low of $256.89 and a 52-week high of $358.88. The company has a 50-day simple moving average of $293.11 and a two-hundred day simple moving average of $309.52.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the business posted $6.72 earnings per share. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s payout ratio is currently 32.97%.

Hedge Funds Weigh In On Cigna Group

A number of hedge funds have recently modified their holdings of the company. Family Legacy Inc. boosted its position in shares of Cigna Group by 0.5% in the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock worth $2,138,000 after purchasing an additional 31 shares during the period. Impact Investors Inc boosted its position in shares of Cigna Group by 1.6% during the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock worth $650,000 after acquiring an additional 31 shares during the last quarter. Mission Wealth Management LP boosted its position in shares of Cigna Group by 1.5% during the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock worth $691,000 after acquiring an additional 32 shares during the last quarter. Westend Capital Management LLC boosted its position in shares of Cigna Group by 8.1% during the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock worth $140,000 after acquiring an additional 32 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC boosted its position in shares of Cigna Group by 26.8% during the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock worth $53,000 after acquiring an additional 34 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CI. Royal Bank Of Canada reiterated an “outperform” rating and issued a $371.00 price target on shares of Cigna Group in a research note on Thursday, June 26th. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Guggenheim restated a “buy” rating and set a $350.00 target price (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday. Finally, Robert W. Baird set a $372.00 target price on shares of Cigna Group in a research report on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $372.69.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.